earnings
confidence high
sentiment positive
materiality 0.75
Inspire Medical Q1 rev $201.3M (+23% YoY), EPS $0.10; raises FY EPS guidance to $2.20-$2.30
Inspire Medical Systems, Inc.
2025-Q1 EPS reported
$0.10
revenue$201,317,000
- Revenue $201.3M, up 23% YoY; U.S. revenue $193.6M (+24%), OUS $7.7M (-6%).
- Net income $3.0M (diluted EPS $0.10) vs net loss $10.0M ($0.34 loss) in Q1 2024.
- Adjusted EBITDA $33.2M, up from $11.9M; operating loss improved 90% to $1.5M.
- Surpassed 100,000 patients on Inspire therapy; Inspire V system launch starting in U.S. May 2025.
- FY 2025 revenue guidance maintained $940-955M; EPS guidance raised to $2.20-$2.30 (from $2.10-$2.20).